Given the emerging evidence of proliferative and potentially anti-apoptotic actions of INSR, we investigated in the present paper the regulation of the INSR gene promoter by wild-type and mutant p53 in breast cancer cells. The gene discussed is INSR; the disease is breast carcinoma.